SI-BONE, Inc. (NASDAQ:SIBN) Q2 2023 Earnings Call Transcript August 7, 2023 SI-BONE, Inc. misses on earnings expectations. Reported EPS is $-0.3 EPS, expectations were $0.41. Operator: Good afternoon, and welcome to SI-BONE’s Second Quarter Earnings Conference Call. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the […]
SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) has earned an average recommendation of “Buy” from the seven brokerages that are covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average twelve-month price target among analysts that have issued a report on the stock in the last year is […]
SI-BONE (NASDAQ:SIBN – Free Report) had its price target upped by Truist Financial from $28.00 to $33.00 in a report issued on Wednesday, FlyOnTheWall reports. A number of other research firms have also recently commented on SIBN. Needham & Company LLC lifted their target price on SI-BONE from $27.00 to $32.00 in a research report […]
SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) traded down 2.5% during mid-day trading on Tuesday . The stock traded as low as $25.21 and last traded at $25.83. 78,965 shares were traded during mid-day trading, a decline of 77% from the average session volume of 349,438 shares. The stock had previously closed at $26.48. Wall […]
19.07.2023 - SANTA CLARA, Calif., July 19, 2023 (GLOBE NEWSWIRE) - SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the .